XPeng, Inc. ADR (XPEV)
NYSE:XPEV
Want to see XPEV full AI Analyst Report?
Top Page
XPeng, Inc. ADR
(NYSE:XPEV)
Select Model
Select Model
Rating:53Neutral
Price Target:
$18.00
▼(-0.55% Downside)
Action:ReiteratedDate:04/21/26
The score is primarily supported by improving financial performance (strong growth, margin recovery, and positive 2025 operating/free cash flow). This is tempered by continued lack of sustained profitability, higher leverage, and a mixed technical setup, while valuation remains unattractive on earnings-based metrics (negative P/E). Earnings-call guidance and momentum were positive but carry sizable execution and cost risks.
Positive Factors
Robust volume growth
Sustained, large percentage delivery growth demonstrates successful product-market fit and rapidly expanding scale. Higher volumes underpin revenue stability, improve factory utilization and bargaining power with suppliers, and create a base for longer-term margin expansion as fixed costs are spread over more units.
Negative Factors
Rising leverage
A sharp increase in leverage materially raises refinancing and interest-cost risk if operating improvements stall. Higher debt limits financial flexibility for opportunistic investments, increases cash flow sensitivity to macro stress, and may force trade-offs between growth spending and balance-sheet repair.
Read all positive and negative factors
Positive Factors
Negative Factors
Robust volume growth
Sustained, large percentage delivery growth demonstrates successful product-market fit and rapidly expanding scale. Higher volumes underpin revenue stability, improve factory utilization and bargaining power with suppliers, and create a base for longer-term margin expansion as fixed costs are spread over more units.
Read all positive factors
XPeng, Inc. ADR (XPEV) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$15.19B
Dividend YieldN/A
Average Volume (3M)6.51M
Price to Earnings (P/E)44.8
Beta (1Y)0.93
Revenue Growth88.10%
EPS Growth80.63%
CountryUS
Employees15,364
SectorConsumer Cyclical
Sector Strength84
IndustryAuto - Manufacturers
Share Statistics
EPS (TTM)-4.52
Shares Outstanding782,873,100
10 Day Avg. Volume4,716,093
30 Day Avg. Volume6,511,110
Financial Highlights & Ratios
PEG Ratio1.00
Price to Book (P/B)2.22
Price to Sales (P/S)0.90
P/FCF Ratio13.74
Enterprise Value/Market Cap7.14
Enterprise Value/Revenue1.80
Enterprise Value/Gross Profit11.43
Enterprise Value/Ebitda-27.65
Forecast
1Y Price Target
$24.57Price Target Upside35.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)-0.37
Revenue Forecast (FY)$96.67B
XPeng, Inc. ADR Business Overview & Revenue Model
Company Description
XPeng Inc. designs, develops, manufactures, and markets smart electric vehicles in the People's Republic of China. It offers SUVs under the G3 and G3i names; four-door sports sedans under the P7 name; and family sedans under the P5 name. The compa...
How the Company Makes Money
XPeng primarily makes money by selling smart electric vehicles to customers, which is recorded as automotive sales revenue. It also generates revenue from providing related services, which can include items such as maintenance and repair services,...
XPeng, Inc. ADR Key Performance Indicators (KPIs)
Any
Vehicle Deliveries
Tracks the number of vehicles delivered to customers, indicating sales performance, market demand, and production efficiency.
Tracks the number of vehicles delivered to customers, indicating sales performance, market demand, and production efficiency.
Data provided by:
The Fly
The FlyXPeng, Inc. ADR Earnings Call Summary
Earnings Call Date:Mar 20, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 27, 2026
Earnings Call Sentiment Positive
The call presented strong operational and financial progress: record deliveries (+126% YoY), robust revenue growth (Q4 revenue +38.2% YoY), margin expansion and the company’s first positive quarterly net profit. Management reiterated aggressive investments and ambitious product and global expansion plans (VLA 2.0 rollout, Turing SoC scale-up, robotaxi pilots, and humanoid robot mass production targets). Key risks highlighted include rising R&D/SG&A, substantial compute and infrastructure needs, regulatory dependency for robotaxi/autonomy, and commercialization challenges for humanoid robots. Overall the positive metrics, improved margins and cash generation outweigh the operational and execution risks presented.Positive Updates
Record Annual Deliveries and Strong Volume Growth
Annual deliveries reached 429,445 units, up 126% year-over-year, driven by best-selling models in multiple price segments and ramp of new platforms.
Negative Updates
Rising R&D and SG&A Expenses
Q4 R&D expenses were RMB 2.87 billion, up 43.2% YoY and 18.3% QoQ. Q4 SG&A was RMB 2.79 billion, up 22.7% YoY and 12.0% QoQ—reflecting higher product development, marketing and franchise commissions that weigh on near-term operating expense trends.
Read all updates
Q4-2025 Updates
Positive
Negative
Record Annual Deliveries and Strong Volume Growth
Annual deliveries reached 429,445 units, up 126% year-over-year, driven by best-selling models in multiple price segments and ramp of new platforms.
Read all positive updates
Company Guidance
Management guided Q1 2026 deliveries of 61,000–66,000 units and revenue of RMB 12.2–13.2 billion, with March deliveries expected to rise sequentially 69%–101% month‑over‑month; for 2026 they target overseas deliveries to double year‑over‑year (from ~45,000 in 2025) and international revenue to exceed 20%, supported by plans to double overseas stores to ~680 and expand its ultrafast charging network to 10 key markets. They plan to launch four new global models in 2026 (GX preorders in Q3; GX is a 6‑seat, L4‑capable SUV), roll out VLA 2.0 broadly (edge model parameters to scale from several billion to ~20 billion by year‑end, average miles per takeover to improve ~25x and safety‑critical miles per takeover ~50x), target Turing SoC shipments of nearly 1 million units this year after >200,000 shipped since Q3, begin robotaxi pilot passenger operations and overseas road testing in H2 2026, and ramp IRON humanoid robot mass production with a >1,000 units/month target by year‑end; physical‑AI R&D investment is planned at RMB 7 billion in 2026.XPeng, Inc. ADR Financial Statement Overview
Summary
Income Statement
48
Neutral
Balance Sheet
45
Neutral
Cash Flow
62
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.29B | 74.63B | 40.87B | 30.68B | 26.86B | 20.99B |
| Gross Profit | 9.49B | 14.08B | 5.85B | 451.15M | 3.09B | 2.62B |
| EBITDA | -3.92B | -4.30B | -2.91B | -8.02B | -7.58B | -3.94B |
| Net Income | -4.28B | -1.11B | -5.79B | -10.38B | -9.14B | -4.86B |
Balance Sheet | ||||||
| Total Assets | 92.43B | 103.23B | 82.71B | 84.16B | 71.49B | 65.65B |
| Cash, Cash Equivalents and Short-Term Investments | 33.87B | 38.93B | 32.72B | 31.67B | 31.22B | 39.72B |
| Total Debt | 30.67B | 37.38B | 15.94B | 15.39B | 12.83B | 5.05B |
| Total Liabilities | 62.09B | 72.84B | 51.43B | 47.83B | 34.58B | 23.50B |
| Stockholders Equity | 30.34B | 30.39B | 31.27B | 36.33B | 36.91B | 42.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.91B | -4.44B | -1.36B | -12.91B | -5.41B |
| Operating Cash Flow | 0.00 | 8.26B | -2.01B | 956.16M | -8.23B | -1.09B |
| Investing Cash Flow | 0.00 | -7.33B | -1.26B | 631.17M | 4.85B | -33.08B |
| Financing Cash Flow | 0.00 | 514.76M | 669.32M | 8.02B | 6.00B | 14.63B |
XPeng, Inc. ADR Technical Analysis
Neutral
18.10
Price Trends
17.90
Positive
18.83
Negative
19.99
Negative
Market Momentum
-0.09
Negative
52.11
Neutral
75.47
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XPEV, the sentiment is Neutral. The current price of 18.1 is above the 20-day moving average (MA) of 17.71, above the 50-day MA of 17.90, and below the 200-day MA of 19.99, indicating a neutral trend. The MACD of -0.09 indicates Negative momentum. The RSI at 52.11 is Neutral, neither overbought nor oversold. The STOCH value of 75.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for XPEV.
XPeng, Inc. ADR Risk Analysis
XPeng, Inc. ADR disclosed 115 risk factors in its most recent earnings report. XPeng, Inc. ADR reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 3 New Risks
1.
We and certain of our directors and officers may be named as defendants in one or several shareholder class action lawsuits. Q4, 2023
2.
We recorded a significant amount of indefinite-lived intangible assets and goodwill in connection with our acquisitions, and we may incur material impairment charges to our indefinite-lived intangible assets and goodwill if the recoverability of these assets become substantially reduced. Q4, 2023
3.
We have entered into collaborations, and may establish or seek collaborations, and we may not timely realize the benefits of such arrangements. Q4, 2023
XPeng, Inc. ADR Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | $14.93B | 79.91 | -984.82% | ― | 33.72% | 36.29% | |
56 Neutral | $18.24B | 4,652.09 | 1.55% | ― | -22.18% | -86.28% | |
53 Neutral | $15.19B | 44.76 | -3.77% | ― | 88.10% | 80.63% | |
47 Neutral | $9.99B | -1.46 | 57.07% | ― | 97.73% | -20.91% | |
46 Neutral | $17.87B | -11.30 | -69.98% | ― | 10.43% | 21.58% | |
45 Neutral | $2.00B | -7.61 | -293.86% | ― | 61.03% | -5.36% |
* Consumer Cyclical Sector Average
XPEV
XPeng, Inc. ADR
15.55
-4.08
-20.78%
NIO
Nio
5.87
1.90
47.86%
LI
Li Auto
17.60
-9.03
-33.91%
LCID
Lucid Group
6.05
-19.05
-75.90%
VFS
VinFast Auto
4.27
0.55
14.78%
RIVN
Rivian Automotive
14.18
-0.08
-0.56%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.